191 related articles for article (PubMed ID: 33866470)
1. ASO Author Reflections: Gastric Cancer with Peritoneal Metastasis: Are Some Patients Surgical Candidates?
Pimiento JM; Dineen SP
Ann Surg Oncol; 2021 Aug; 28(8):4138-4139. PubMed ID: 33866470
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.
Chia DKA; Ang JJ; Sundar R; Kim G; Shabbir A; So JBY; Yong WP
Ann Surg Oncol; 2022 Dec; 29(13):8606-8607. PubMed ID: 36192514
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
Leinwand JC; Kluger MD
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):742-743. PubMed ID: 32239340
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?
García-Fadrique A
Ann Surg Oncol; 2022 Jan; 29(1):203-204. PubMed ID: 34435299
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Long-Term Outcomes After R0 Resection of Colorectal Peritoneal Metastasis.
Shida D
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):832-833. PubMed ID: 30251024
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Current Status of Treatment of Peritoneal Carcinomatosis from Gastric Cancer Origin in Spain: Is It Possible to Cure These Patients?
Manzanedo I; Pereira F
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):792-793. PubMed ID: 31628556
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: The Peritoneum is an Active Immunological Compartment.
Thorgersen EB; Flatmark K
Ann Surg Oncol; 2021 Sep; 28(9):5263-5264. PubMed ID: 33939046
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer.
Sammartino P; Cornali T
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):882-883. PubMed ID: 30288653
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Tailoring the Extent of Peritoneal Resection for Peritoneal Metastases According to the Primary Tumor Site.
Bhatt A; Glehen O
Ann Surg Oncol; 2020 May; 27(5):1471-1472. PubMed ID: 32162077
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Troponin I2-A Specific Biomarker for Detection and Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):709-710. PubMed ID: 30264252
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Molecular Profiling Can Provide Personalized Clinical Guidance in the Management of Peritoneal Malignancies.
Moaven O; Miller LD; Levine EA
Ann Surg Oncol; 2020 Dec; 27(13):5024-5025. PubMed ID: 32749622
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: What Is the Best Treatment for Gastric Cancer with Positive Peritoneal Lavage Cytology or Localized Peritoneum Metastasis?
Yamaguchi T; Takashima A; Boku N
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):737-738. PubMed ID: 31802300
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Contemporary Management Trends in Malignant Peritoneal Mesothelioma.
Calthorpe L; Alseidi A; Adam MA
Ann Surg Oncol; 2023 Aug; 30(8):5130. PubMed ID: 37142837
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?
Kepenekian V; Kefleyesus A; Passot G; Rousset P; Benzerdjeb N; You B; Peron J; Glehen O
Ann Surg Oncol; 2023 Jun; 30(6):3316-3317. PubMed ID: 36752969
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases.
Vierra M; Bansal VV; Shergill A; Turaga KK; Eng OS
Ann Surg Oncol; 2024 Jan; 31(1):655-656. PubMed ID: 37803088
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters.
Choi AH; Senthil M
Ann Surg Oncol; 2020 Dec; 27(13):4949. PubMed ID: 32627117
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Time to Change: Redefining "Complete Cytoreduction" in Appendiceal Carcinomatosis.
Munoz-Zuluaga C; King MC; Gushchin V; Sardi A
Ann Surg Oncol; 2020 Dec; 27(13):5037-5038. PubMed ID: 32935268
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Prognosticating the Treatment Outcome for Primary Peritoneal Surface Malignancy: Time for an Overhaul of Scoring Systems?
Ihemelandu C
Ann Surg Oncol; 2023 Mar; 30(3):1838-1839. PubMed ID: 36629992
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Cisplatin- and Adrenaline-Based Intraperitoneal Chemotherapy Protocol for Ovarian Peritoneal Carcinosis: New Perspectives?
Paquette B
Ann Surg Oncol; 2022 May; 29(5):3335-3336. PubMed ID: 35072865
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Using the Gastric Cancer Peritoneal Carcinomatosis Risk Score to Inform Surveillance and Treatment.
Selleck M; Senthil M
Ann Surg Oncol; 2020 Jan; 27(1):248-249. PubMed ID: 31659634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
